A thymus-derived dipeptide with broad immunomodulatory, antioxidant, and longevity-associated effects.
A synthetic dipeptide (Lys-Glu) originally isolated from thymic tissue. Activates natural killer cells, modulates T-helper cell balance (Th1/Th2), reduces excessive oxidative stress, and has been shown in animal studies to extend lifespan. Acts on multiple tissue types, unlike more organ-specific bioregulators.
Animal studies with Vilon have shown consistent lifespan extension across multiple species, making it one of the most studied bioregulators for longevity. It was developed alongside Epithalon by Khavinson and colleagues at the St. Petersburg Institute.
Vilon's broad immunomodulatory effects make it a foundational component of many Russian peptide bioregulator longevity stacks, often paired with Epithalon and Thymalin.